Get startedLog in
    Picture of Initiator Pharma A/S logo

    INIT — Initiator Pharma A/S News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Initiator Pharma Expands FSD Program To Include Vulvodynia

    Picture of Initiator Pharma A/S logoInitiator Pharma A/S
    19/05/2025 06:49
    May 19 (Reuters) - Initiator Pharma A/S INIT.ST:

EXPANDS FSD PROGRAM TO INCLUDE VULVODYNIA

SIGNS FINANCING AGREEMENT WITH MAC CLINICAL RESEARCH WORTH UP TO GBP 2.5 MILLION

PHASE 2A STUDY FOR VULVODYNIA TREATMENT TO START IN H2 2025

Source text: ID:nMFN2x4dmp

Further company coverage: INIT.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Initiator Pharma A/S

    See all news